Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study.

Dothan, David; Raisin, Galiya; Malchi, Nadav; Gordon, Avi; Touitou, Dan; Chertin, Boris

Dothan, David; Raisin, Galiya; Malchi, Nadav; Gordon, Avi; Touitou, Dan; Chertin, Boris.

Afiliación

Dothan D; The Department of Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University, 91031, Jerusalem, Israel.
Raisin G; The Department of Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University, 91031, Jerusalem, Israel.
Malchi N; The Department of Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University, 91031, Jerusalem, Israel.
Gordon A; The Department of Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University, 91031, Jerusalem, Israel.
Touitou D; The Department of Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University, 91031, Jerusalem, Israel.
Chertin B; The Department of Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University, 91031, Jerusalem, Israel. boris.chertin@gmail.com.

Int Urol Nephrol ; 54(9): 2167-2174, 2022 Sep.

Article en En | MEDLINE | ID: mdl-35780464

Asunto(s)

Cistitis Intersticial; Lidocaína; Administración Intravesical; Animales; Cistitis Intersticial/tratamiento farmacológico; Preparaciones de Acción Retardada/uso terapéutico; Lidocaína/efectos adversos; Ácidos Mandélicos; Porcinos

Palabras clave

Bladder pain syndrome; Interstitial Cystitis; Lidocaine; Oxybutynin; Sustained release; TRG-042

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cistitis Intersticial / Lidocaína Límite: Animals Idioma: En Revista: Int Urol Nephrol Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google